If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 105.00
Bid: 102.00
Ask: 108.00
Change: 0.00 (0.00%)
Spread: 6.00 (5.882%)
Open: 105.00
High: 105.00
Low: 105.00
Prev. Close: 105.00
IGP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Settlement of Patent Dispute

25 Mar 2010 12:30

RNS Number : 1650J
Intercede Group PLC
25 March 2010
 



25 March 2010

Intercede Group plc

("Intercede")

Settlement of Patent Litigation Between ActivIdentity and Intercede

Legal Action Terminated in California and UK

Highlights:

·; Intercede announces settlement of patent infringement disputes in the U.S. and the UK

 

·; The parties have settled the U.S. and UK litigations on mutually acceptable terms

 

London, United Kingdom 25 March 2010 - Intercede today announce that they have settled on mutually acceptable terms a lawsuit filed by ActivIdentity in the Northern District of California on 1 October 2008, and a lawsuit filed by Intercede in the UK High Court on 22 December 2009. 

The settlement entered on 23 March 2010 resolves patent litigation brought by ActivIdentity accusing Intercede's MyID products and Intercede's counterclaims alleging invalidity, violations of US antitrust law, fraud and unfair competition. This settlement includes a patent license, and the details of the settlement are confidential.

Richard Parris, Intercede's Chairman and Chief Executive, said:

 "We are pleased to end all outstanding legal disputes between Intercede and ActivIdentity and look forward to progressing our business. This settlement ensures that Intercede's worldwide partners and customers can continue to benefit from our leading MyID Identity and Credential Management System with confidence."

Intercede will take a charge to the current financial year for all of the exceptional costs associated with the legal fees relating to this case. It is not anticipated that the patent license agreement will have a material impact on Intercede's current or future earnings.

About Intercede

Intercede is the producer of the MyID® Identity and Credential Management System (IDCMS). Intercede's MyID is the only IDCMS software product that enables organizations to easily and securely manage the identities of people and their associated identity credentials within a single, integrated, workflow driven platform. This includes enabling and managing: secure registration, biometric capture, application vetting and approval through to smart card personalisation, issuance and management.

Intercede's MyID is being used around the world by large corporations, governments and banks to manage millions of identities for employees, citizens and customers. Notable deployments in the US include 10 Federal Agencies, a program with Lockheed Martin and two major US financial institutions. In Europe and the Middle East, Intercede's MyID is being deployed in support of government identity, health and corporate employee ID security projects.

For more information visit http://www.intercede.com

 

ENQUIRIES

Intercede Group plc

Richard Parris, Chairman & Chief Executive

Andrew Walker, Finance Director

Tel. +44 (0)1455 558111

FinnCap

Clive Carver /Charles Cunningham - Corporate Finance

Joanna Weaving - Corporate Broking

Tel. +44 (0)20 7600 1658

Pelham Public Relations

Archie Berens

Tel. +44 (0)20 7337 1509

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGMGZFRKZGGZG
Date   Source Headline
1st Feb 20107:00 amRNSNew Aerospace and Defence Contract Win
18th Jan 20104:36 pmRNSDirector/PDMR Shareholding
8th Dec 20097:00 amRNSInterim Results
11th Nov 20097:00 amRNSNew Middle East Contract Win
26th Oct 20097:00 amRNSRelease of latest Version of MyID / New Customers
12th Oct 20097:00 amRNSNational Identity Project in Kuwait
7th Oct 20097:00 amRNSTrading Update
17th Sep 20093:57 pmRNSResult of AGM
29th Jun 20095:11 pmRNSTotal Voting Rights
10th Jun 20097:00 amRNSFinal Results
8th Jun 20095:28 pmRNSDirector/PDMR Shareholding
1st Jun 20097:00 amRNSConversion of Loan Notes
14th May 20097:00 amRNSNew Contract with European Bank
30th Apr 20097:00 amRNSNew European Government Contract
2nd Apr 20097:00 amRNSTrading Update
1st Apr 20097:00 amRNSChange of Adviser
31st Mar 20097:00 amRNSTotal Voting Rights
30th Mar 20097:00 amRNSMaritime Credentialing Program Update
10th Mar 200910:21 amRNSAdditional Listing
5th Feb 20097:00 amRNSPositive Trading Update
12th Jan 20097:00 amRNSContract with BT for NHS Nat'l Data Spine
8th Jan 20097:00 amRNSIntercede Technology Used by Queensland Police
15th Dec 20089:45 amRNSDirector's Share Purchase
15th Dec 20087:00 amRNSNew Contract with Lockheed Martin
9th Dec 20087:00 amRNSInterim Results
4th Dec 20087:00 amRNSNew Contracts
25th Nov 20087:00 amRNSNew Reseller Agreement
17th Nov 20087:00 amRNSNew Reseller Partnership
22nd Oct 20087:00 amRNSRe: US Maritime Credentialing Program
6th Oct 20087:00 amRNSStatement Re ActivIdentity Patent Claim
6th Oct 20087:00 amRNSPositive Trading Update
29th Sep 20087:00 amRNSSubcontract With Lockheed Martin
17th Sep 200810:37 amRNSDirector/PDMR Shareholding
27th Aug 200810:26 amRNSDirector/PDMR Shareholding
20th Aug 20087:00 amRNSAppointment of Global Sales D
25th Jul 20087:00 amRNSDirector/PDMR Shareholding
24th Jul 20087:00 amRNSTrading Update
30th May 20087:00 amRNSTotal Voting Rights
20th May 20087:00 amRNSFinal Results
14th May 20087:00 amRNSAdditional Listing
2nd May 200810:33 amRNSResponse to Press Speculation
11th Apr 20087:00 amRNSTrading Update
14th Feb 20087:00 amRNSTrading Update
17th Dec 200711:58 amRNSDirector Share Dealings
11th Dec 20077:01 amRNSInterim Results
3rd Oct 20077:00 amRNSTrading Update
6th Sep 20077:01 amRNSFurther Re Licence
30th Aug 20077:01 amRNSNew Licence Agreement
16th Aug 200710:01 amRNSAIM Rule 26
31st May 20077:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.